KREBS BIOCHEMICALS & INDUSTRIES LTD.-$ Q1 FY27 Results
KREBSBIOQ1 FY27 ResultsAnnounced 6 Aug, 1:42 pmResult:Weak· Market: Flat#Base effect
| Metric | Value (₹ Cr) | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue | 6.98 | 2.6% | 27.4% |
| Total Income | 7.14 | 19.0% | 30.0% |
| Expenditure | 9.62 | 13.7% | 11.0% |
| PBT | -2.48 | 6.2% | 53.3% |
| Net Profit | -2.48 | 6.2% | 53.3% |
| OPM | 11.84% | 24.58pp | 49.92pp |
| NPM | -34.80% | 8.25pp | 62.14pp |
| EPS | 1.15 | 5.5% | 53.4% |
Pharma/manufacturing lens: revenue grew 27.4% YoY but the company remains loss-making (not a turnaround) with negative NPM, so it stays capped in the weak band despite the smaller loss versus a depressed base.
Informational and educational content only. Not investment advice.